[1] 谢院生, 刘晓峦, 陈香美. 横纹肌溶解致急性肾损伤的诊治[J]. 中国血液净化杂志, 2009 8(3): 120－123．
[2] KHAN F Y, IBRAHIM W. Rosuvastatin induced rhabdomyolysis in a low risk patient：a case report and review of the literature[J]. Curr Clin Pharmacol, 2009, 4(1): 1-3.
[3] GONZáLEZ-SáNCHEZ M I, MANJABACAS M C, GARCíACARMONA F, et al. Mechanism of acetaminophen oxidation by the peroxidase-like activity of methemoglobin[J]. Chem Res Toxicol, 2009, 22(11):1841-1850.
[4] REITER K, BELLOMO R, RONCO C, et al. Pro/con clinical hemofiltration: is high-volume hemofiltration beneficial in the treatment of septic shock? [J]. Critical Care, 2002, 6 (1): 18-21.
[5] 朱虎成, 陈春梅, 赵德, 等. 他汀类药物导致的肌病及其致病机制研究进展[J]. 中国抗生素杂志, 2011, 36(9): 651-653, 715.
[6] 黄惠明. 2008－2013 年他汀类药物致横纹肌溶解症文献分析[J]. 中国药物应用与监测, 2014, 11(2): 107-110.
[7] 马志宇, 苏靖翠, 佟淼, 等. 124例横纹肌溶解征诊治体会[J]. 中国医科大学学报, 2013, 42(10): 953－954.
[8] BOUTAUD O, MOORE K P, REEDER B J, et al. Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure. Proc Natl Acad Sci USA, 2010, 107(6): 2699-2704．
[9] 孟建中, 李丹丹. 连续性血液滤过剂量的选择对危重型横纹肌溶解症预后的影响[J]. 中国血液净化, 2011, 10(10): 552-555.
|
